ADCs (Antibody Drug Conjugates) combine the best of two modalities, toxic efficacy and antibody specificity. The result is an improved therapeutic window with fewer side effects. However, the bioanalytical requirements for PK analysis also require a multifaceted approach. Here-in we describe various mass spectrometry based strategies Frontage has successfully applied in the bioanalysis of ADC’s for clinical and preclinical studies.
信息图

ADC 2019

ADCs (Antibody Drug Conjugates) combine the best of two modalities, toxic efficacy and antibody specificity. The result is an improved therapeutic window with fewer side effects. However, the bioanalytical requirements for PK analysis also require a multifaceted approach. Here-in we describe various mass spectrometry based strategies Frontage has successfully applied in the bioanalysis of ADC’s for clinical and preclinical studies.

下载报名

提交注册以获得对内部资源的访问权限。

  • 这个字段是用于验证目的，应该保持不变。
  • 请只点击一次提交按钮。
zh_CNChinese
en_USEnglish zh_CNChinese